Description
This course provides a comprehensive, evidence-informed overview of Menopausal Hormone Therapy (MHT) with a focused exploration of progesterone’s role in contemporary menopause care. Designed for clinicians seeking to enhance their confidence and precision in prescribing MHT, the session integrates current guidelines, clinical evidence, and practical application strategies.
Participants will begin with a review of leading consensus statements from organizations such as The Menopause Society (TMS), International Menopause Society (IMS), Canadian Menopause Society (CMS), and the Society of Obstetricians and Gynaecologists of Canada (SOGC). Emphasis is placed on appropriate indications, contraindications, and risk stratification to support safe and individualized patient care. The course also examines key considerations in selecting routes of administration, formulations, and dosing strategies, highlighting the clinical differences between oral and transdermal estrogen, as well as the role of progestogens in endometrial protection.
A central component of the course is a deep dive into progesterone, with particular attention to oral micronized progesterone (OMP). Participants will explore its pharmacology, distinctions from synthetic progestins, and its broader physiological roles beyond endometrial protection. Current evidence will be reviewed regarding progesterone’s impact on sleep quality, vasomotor symptoms, mood, and anxiety, along with emerging insights into additional therapeutic benefits.
Safety remains a core focus throughout, with discussion of common side effects, breast health considerations, progesterone intolerance, and appropriate management strategies. Special populations and clinical nuances are also addressed to support thoughtful, patient-centered prescribing.
The course concludes with case-based discussions and practical clinical pearls that translate evidence into real-world application. Attendees will refine their ability to communicate risk–benefit considerations, tailor MHT protocols to individual patient profiles, and navigate complex clinical scenarios with greater clarity and confidence.
Learning Objectives
1. Critically appraise current evidence and guidelines on menopause hormone therapy (MHT) and apply this knowledge to clinical decision-making in midlife care.
2. Describe the multifaceted role of progesterone within MHT, including the safety and clinical applications of oral micronized progesterone (OMP).
3. Integrate MHT into patient care through practical, patient-centered strategies informed by clinical pearls and case-based learning.
Accreditation: 1.25 Cat A Credits in Pharmacology Approved (CONO) / 1.5 Cat F Credits Approved (CNPBC)
Title: Trauma and the Body: Integrating Mind-Body Health
Speaker Name: Dr. Daiana Castleman MSCP, ND
Price: $49.99 CAD









